Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)
CompletedOBSERVATIONAL
Enrollment
33
Participants
Timeline
Start Date
January 31, 2006
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
Conditions
Rheumatoid Arthritis
Interventions
DRUG
Infliximab
Infliximab given in accordance with the local summary of product characteristics
All Listed Sponsors
lead
Merck Sharp & Dohme LLC
INDUSTRY
NCT00724243 - Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED) | Biotech Hunter | Biotech Hunter